Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Nociceptors are functionally male or female: from mouse to monkey to man

View through CrossRef
Abstract The prevalence of many pain conditions often differs between sexes. In addition to such quantitative distinctions, sexual dimorphism may also be qualitative reflecting differences in mechanisms that promote pain in men and women. A major factor that influences the likelihood of pain perception is the threshold for activation of nociceptors. Peripheral nociceptor sensitization has been demonstrated to be clinically relevant in many pain conditions. Whether peripheral nociceptor sensitization can occur in a sexually dimorphic fashion, however, has not been extensively studied. To address this fundamental knowledge gap, we used patch clamp electrophysiology to evaluate the excitability of dorsal root ganglion neurons from male or female rodents, non-human primates, and humans following exposure to putative sensitizing agents. Previous studies from our laboratory, and others, have shown that prolactin promotes female-selective pain responses in rodents. Consistent with these observations, dorsal root ganglion neurons from female, but not male, mice were selectively sensitized by exposure to prolactin. The sensitizing action of prolactin was also confirmed in dorsal root ganglion neurons from a female macaque monkey. Critically, neurons recovered from female, but not male, human donors were also selectively sensitized by prolactin. In the course of studies of sleep and pain, we unexpectedly observed that an orexin antagonist could normalize pain responses in male animals. We found that orexin B produced sensitization of male, but not female, mouse, macaque, and human dorsal root ganglion neurons. Consistent with functional responses, increased prolactin receptor and orexin receptor 2 expression was observed in female and male mouse dorsal root ganglia, respectively. Immunohistochemical interrogation of cultured human sensory neurons and whole dorsal root ganglia also suggested increased prolactin receptor expression in females and orexin receptor 2 expression in males. These data reveal a functional double dissociation of nociceptor sensitization by sex, which is conserved across species and is likely directly relevant to human pain conditions. To our knowledge, this is the first demonstration of functional sexual dimorphism in human sensory neurons. Patient sex is currently not a common consideration for the choice of pain therapy. Precision medicine, based on patient sex could improve therapeutic outcomes by selectively targeting mechanisms promoting pain in women or men. Additional implications of these findings are that the design of clinical trials for pain therapies should consider the proportions of male or female patients enrolled. Lastly, re-examination of selected past failed clinical trials with subgroup analysis by sex may be warranted.
Title: Nociceptors are functionally male or female: from mouse to monkey to man
Description:
Abstract The prevalence of many pain conditions often differs between sexes.
In addition to such quantitative distinctions, sexual dimorphism may also be qualitative reflecting differences in mechanisms that promote pain in men and women.
A major factor that influences the likelihood of pain perception is the threshold for activation of nociceptors.
Peripheral nociceptor sensitization has been demonstrated to be clinically relevant in many pain conditions.
Whether peripheral nociceptor sensitization can occur in a sexually dimorphic fashion, however, has not been extensively studied.
To address this fundamental knowledge gap, we used patch clamp electrophysiology to evaluate the excitability of dorsal root ganglion neurons from male or female rodents, non-human primates, and humans following exposure to putative sensitizing agents.
Previous studies from our laboratory, and others, have shown that prolactin promotes female-selective pain responses in rodents.
Consistent with these observations, dorsal root ganglion neurons from female, but not male, mice were selectively sensitized by exposure to prolactin.
The sensitizing action of prolactin was also confirmed in dorsal root ganglion neurons from a female macaque monkey.
Critically, neurons recovered from female, but not male, human donors were also selectively sensitized by prolactin.
In the course of studies of sleep and pain, we unexpectedly observed that an orexin antagonist could normalize pain responses in male animals.
We found that orexin B produced sensitization of male, but not female, mouse, macaque, and human dorsal root ganglion neurons.
Consistent with functional responses, increased prolactin receptor and orexin receptor 2 expression was observed in female and male mouse dorsal root ganglia, respectively.
Immunohistochemical interrogation of cultured human sensory neurons and whole dorsal root ganglia also suggested increased prolactin receptor expression in females and orexin receptor 2 expression in males.
These data reveal a functional double dissociation of nociceptor sensitization by sex, which is conserved across species and is likely directly relevant to human pain conditions.
To our knowledge, this is the first demonstration of functional sexual dimorphism in human sensory neurons.
Patient sex is currently not a common consideration for the choice of pain therapy.
Precision medicine, based on patient sex could improve therapeutic outcomes by selectively targeting mechanisms promoting pain in women or men.
Additional implications of these findings are that the design of clinical trials for pain therapies should consider the proportions of male or female patients enrolled.
Lastly, re-examination of selected past failed clinical trials with subgroup analysis by sex may be warranted.

Related Results

BMP Signaling Downstream of the Highwire E3 Ligase Sensitizes Nociceptors
BMP Signaling Downstream of the Highwire E3 Ligase Sensitizes Nociceptors
AbstractA comprehensive understanding of the molecular machinery important for nociception is essential to improving the treatment of pain. Here, we show that the BMP signaling pat...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract Introduction Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
[RETRACTED] Rhino XL Male Enhancement v1
[RETRACTED] Rhino XL Male Enhancement v1
[RETRACTED]Rhino XL Reviews, NY USA: Studies show that testosterone levels in males decrease constantly with growing age. There are also many other problems that males face due ...
P009 IL-17 mediates visceral hypersensitivity by sensitising colonic nociceptors
P009 IL-17 mediates visceral hypersensitivity by sensitising colonic nociceptors
Abstract Background Comparison of cytokine expression in colitic tissue with respective cytokine receptor expression in pain sen...
Epidemiology of human Monkey-pox cases in Rivers State, Nigeria January 2017-June 2022
Epidemiology of human Monkey-pox cases in Rivers State, Nigeria January 2017-June 2022
The resurgence in monkey pox disease has posed a global health threat. Nigeria recorded increased number of reported monkey pox cases in 2017, with cases occurring in subsequent ye...
Cellular and Molecular Mechanisms of Pain Control by Opiates
Cellular and Molecular Mechanisms of Pain Control by Opiates
Most prescribed analgesics take advantage a complex and dynamic opioid neurotransmission system endogenous to all mammals, capable of relieving the pain of a recent injury while le...

Back to Top